Joseph J. Kim

Cooley advised SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, on its acquisition by Eli Lilly.

Cooley advised DataStax, an artificial intelligence (AI) and data solution provider, on its acquisition by IBM (NYSE: IBM), a provider of global hybrid cloud and AI solutions and consulting expertise.

Cooley represented Auditoria.AI in its $38 million Series B financing led by Innovius Capital, with participation from Dell Technologies Capital, Sentinel Global and existing investors including Venrock, Neotribe Ventures, Engineering Capital and KPMG Ventures. Partner Sale Kwon led the Cooley team advising Auditoria.AI, an artificial intelligence-driven software as a service automation provider for corporate finance that automates finance processes in vendor management, accounts payable and receivable, and accruals to accelerate cash performance.

Cooley advised SiteOne Therapeutics, a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough and other conditions, on its $100 million Series C financing.

Cooley advised a16z on its $20 million Series A investment in knownwell, which provides in-person and virtual primary care and metabolic healthcare. Partner Josh Seidenfeld led the Cooley team advising a16z, a venture capital firm in Silicon Valley that invests in bold founders, innovators and entrepreneurs building the future through technology.

Read more